A Study of Change in Imaging Biomarkers of Dementia with Lewy Bodies (DLB) and Associations with Cognitive and Functional Decline

Overview

Información sobre este estudio

Longitudinal Imaging Biomarkers of Disease Progression in Prodromal and Overt DLB

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Diagnosis of dementia will be based on the DSM-IV criteria, and diagnosis of probable DLB will be based on the 4th Consortium Criteria and prodromal DLB (MCI-LB) based on the research criteria by McKeith et al.
  • At least 18 years of age.
  • Have a reliable informant who personally speaks with or sees that subject at least weekly.
  • Subject is sufficiently fluent in English to complete all measures.
  • Subject must be willing and able to consent to the protocol and undergo up to 6 visits. Baseline visit, 6 month visit and then yearly evaluations (year 1, 2, 3, and 4 from the baseline visit).
  • Subject must be willing and able to undergo neuropsychological testing.
  • Subject must have no contraindication to MRI imaging.

Exclusion Criteria:

  • Presence of another neurologic disorder which could impact findings, such as multiple sclerosis, brain tumors, etc.
  • Subject is unwilling to return for follow-up yearly, undergo neuropsychological testing and MR imaging.
  • If undergoing Tau imaging cannot have QT Prolongation.
  • Subject has no reliable informant.

Eligibility last updated 10/13/21. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Bradley Boeve, M.D.

Abierto para la inscripción

Contact information:

Alzheimer’s Disease Research Center

(507) 284-1324

Jacksonville, Fla.

Investigador principal de Mayo Clinic

Neill Graff Radford, M.D.

Abierto para la inscripción

Contact information:

Memory Disorder Clinic - FL

(904)953-6523

More information

Publicaciones

Publications are currently not available